Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
Date | Title | Source |
---|---|---|
2024-03-11 4:1:48 am | ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM® | GlobeNewsWire |
2024-03-08 7:46:0 am | MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag | Zacks |
2024-03-07 9:34:0 am | Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales | Zacks |
2024-03-07 7:47:0 am | Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia | Zacks |
2024-03-06 5:34:0 am | Novo Nordisk (NVO) Down Despite Kidney Outcomes Study Success | Zacks |
2024-03-05 10:48:0 am | Finding Cheap Stocks Under $10 to Buy in March | Zacks |
2024-03-05 10:0:0 am | FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study | Zacks |
2024-03-05 9:0:10 am | Adma Biologics (ADMA) Is Up 4.94% in One Week: What You Should Know | Zacks |
2024-03-05 4:11:0 am | Zacks.com featured highlights Griffon, HNI, ADMA Biologics and First Bank | Zacks |
Please consider a small donation if you think this website provides you with relevant information